Omnipred
Pricing Report NDC 0065-0638-27

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Omnipred (NDC 0065-0638-27) is $13.38080 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 19, 2013.

As a provided by Alcon Laboratories, Inc., this medication is distributed in a 5 mL in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$13.38080
Per ML

Effective Date
Sep 19, 2013
Billable Units
5 ML
Estimated Package Price
$66.90
Data Status
As of Oct 15, 2014
C/I - Chain or Independent Pharmacy
Package NDC
Description
5 mL in 1 BOTTLE, PLASTIC
Generic Benchmark
The generic equivalent rate is $8.63664 (Effective: Sep 17, 2014)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2013, the NADAC wholesale price for (NDC ) has moved within a range of $13.38080 to $13.38080 per ML. Over this the last few weeks period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Historical Note: This product currently has limited pricing history. Trends will be available as more monthly survey data is collected by CMS.
Date Unit Price Unit Source Method Rate
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 19, 2013 $13.38080 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand

Pricing Methodology Legend

  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026